BCYC logo

Bicycle Therapeutics (BCYC) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$526.42 M
+$187.27 M+55.22%

December 31, 2023


Summary


Performance

BCYC Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCYCbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$890.86 M
-$70.50 M-7.33%

September 30, 2024


Summary


Performance

BCYC Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCYCbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

BCYC Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+55.2%-7.3%
3 y3 years+287.1%-7.3%
5 y5 years+730.6%-7.3%

BCYC Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+55.2%-7.3%+203.2%
5 y5-yearat high+471.5%-7.3%+867.1%
alltimeall timeat high+730.6%-7.3%+1400.5%

Bicycle Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$890.86 M(-7.3%)
Jun 2024
-
$961.36 M(+110.4%)
Mar 2024
-
$457.00 M(-13.2%)
Dec 2023
$526.42 M(+55.2%)
$526.42 M(-8.0%)
Sep 2023
-
$572.09 M(+68.0%)
Jun 2023
-
$340.43 M(+15.9%)
Mar 2023
-
$293.81 M(-13.4%)
Dec 2022
$339.15 M(-22.7%)
$339.15 M(-6.2%)
Sep 2022
-
$361.47 M(-3.0%)
Jun 2022
-
$372.77 M(-8.5%)
Mar 2022
-
$407.37 M(-7.1%)
Dec 2021
$438.68 M
$438.68 M(+69.0%)
DateAnnualQuarterly
Sep 2021
-
$259.52 M(+30.6%)
Jun 2021
-
$198.74 M(+1.4%)
Mar 2021
-
$195.90 M(+44.1%)
Dec 2020
$135.99 M(+47.6%)
$135.99 M(-9.2%)
Sep 2020
-
$149.84 M(+54.6%)
Jun 2020
-
$96.91 M(-11.6%)
Mar 2020
-
$109.64 M(+19.0%)
Dec 2019
$92.12 M(+45.3%)
$92.12 M(-4.0%)
Sep 2019
-
$95.95 M(-11.6%)
Jun 2019
-
$108.54 M(+82.8%)
Mar 2019
-
$59.37 M(-6.3%)
Dec 2018
$63.38 M(-6.3%)
$63.38 M
Dec 2017
$67.66 M
-

FAQ

  • What is Bicycle Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Bicycle Therapeutics?
  • What is Bicycle Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Bicycle Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Bicycle Therapeutics?
  • What is Bicycle Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Bicycle Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of BCYC is $526.42 M

What is the all time high annual cash & cash equivalents for Bicycle Therapeutics?

Bicycle Therapeutics all-time high annual cash & cash equivalents is $526.42 M

What is Bicycle Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, BCYC annual cash & cash equivalents has changed by +$187.27 M (+55.22%)

What is Bicycle Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of BCYC is $890.86 M

What is the all time high quarterly cash and cash equivalents for Bicycle Therapeutics?

Bicycle Therapeutics all-time high quarterly cash and cash equivalents is $961.36 M

What is Bicycle Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, BCYC quarterly cash and cash equivalents has changed by -$70.50 M (-7.33%)